EssilorLuxottica Launches Scientific Advisory Committee to Accelerate Innovation Across Life Sciences
EssilorLuxottica has created its first Scientific Advisory Committee, bringing together a distinguished group of globally recognized scientists and visionaries from science, technology, and healthcare. Designed to reinforce the group’s longstanding scientific foundations, the new committee will play a pivotal role in advancing EssilorLuxottica’s mission to empower patients and consumers worldwide.
According to EssilorLuxottica, the committee will serve as a strategic think tank, providing high-level guidance and anticipating future scientific and technological breakthroughs. Its members will collaborate closely with a worldwide network of leading academic and research institutions, exploring new frontiers in the company’s core research domains—from ophthalmology and oculomics to physics, optics, audiology, artificial intelligence, and ethics.
EssilorLuxottica’s Scientific Advisory Committee comprises five influential figures in contemporary scientific research, each celebrated for groundbreaking contributions in their respective fields:
Pr. Alain Aspect, PhD — 2022 Nobel laureate in Physics and 2010 Wolf Prize recipient. Professor at Institut d’Optique Graduate School – Université Paris-Saclay and École Polytechnique; Emeritus CNRS Senior Scientist.
Pr. Alessio Figalli, PhD — 2018 Fields Medal laureate. Chaired Professor and Director of the Institute for Mathematics Research at ETH Zürich.
Pr. Sharon Kujawa, PhD — 2017 Callier Prize winner. Professor of Otolaryngology–Head and Neck Surgery at Harvard Medical School; Principal Investigator at the Eaton-Peabody Laboratories, Mass Eye and Ear.
Pr. José-Alain Sahel, MD — 2024 Wolf Prize winner. Distinguished Professor and Chair of Ophthalmology at the University of Pittsburgh School of Medicine; Emeritus Professor at Sorbonne Université.
Pr. Effy Vayena, PhD — Professor of Bioethics at ETH Zürich and Visiting Lecturer at the Center for Bioethics, Harvard Medical School.
“Building on EssilorLuxottica’s decades of pioneering research and technological breakthroughs, the creation of our first Scientific Advisory Committee marks a defining step in our innovation journey,” said Francesco Milleri, Chairman and CEO, and Paul du Saillant, Deputy CEO, of EssilorLuxottica. “Engaging with some of the most brilliant minds in science allows us to broaden our horizons, explore uncharted territories and translate knowledge into meaningful human impact. Their expert insights will guide our initiatives to advance ophthalmology, audiology, AI, neuroscience and beyond – amplifying the reach of our solutions across the life sciences. Together we’ll continue to shape the future of our industry, driving transformative progress and reaffirming our commitment to lead with purpose.”